Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.87 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.73 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.60 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.124.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-9921.83South Korea
GJ.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.610EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.286EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.275EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.419EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.151EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used